Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343)

Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343)

Bibliographic Details
Main Authors: Serra, V., Eichhorn, Pieter, García-García, C., Ibrahim, Y., Prudkin, L., Sánchez, G., Rodríguez, O., Antón, P., Parra, J., Marlow, S., Scaltriti, M., Pérez-Garcia, J., Prat, A., Arribas, J., Hahn, W., Kim, S., Baselga, J.
Format: Journal Article
Published: American Society for Clinical Investigation 2014
Online Access:http://hdl.handle.net/20.500.11937/71201

Internet

http://hdl.handle.net/20.500.11937/71201

Similar Items